• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用CRISPR生成全基因人源化,并检测P301L和G272V临床变体,以及创建和位点的缺失无效等位基因。

The use of CRISPR to generate a whole-gene humanized and the examination of P301L and G272V clinical variants, along with the creation of deletion null alleles of and loci.

作者信息

Lins Jeremy, Hopkins Christopher E, Brock Trisha, Hart Anne C

机构信息

Department of Neuroscience, Brown University, Providence, RI 02912.

InVivo Biosystems, Eugene, OR, 79402.

出版信息

MicroPubl Biol. 2022 Sep 19;2022. doi: 10.17912/micropub.biology.000615. eCollection 2022.

DOI:10.17912/micropub.biology.000615
PMID:36204657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9530923/
Abstract

To study important genes involved in Frontotemporal Dementia ( , and ), we created deletion alleles in the three orthologous genes ( , , and ). Simultaneously, we replaced the gene with the predicted orthologous human gene, often called whole-gene humanization, which allows direct assessment of conserved gene function, as well as the opportunity to examine consequences of clinical disease-associated patient variations. Each gene was manipulated using a different selection strategy, including a novel strategy using an mutation rescue technique. Clinical ALS/FTD missense variants G272V and P301L were successfully inserted in . Neither loss or clinical variants caused neuronal defects in young adult or aged , based on examination of glutamatergic phasmid neurons. Yet, we noted decreased survival to day 9 in the P301L strain, compared to control strains. Based on these results, we comment on strategies for humanization, including the importance of confirming gene predictions and identifying loss of function defects for each gene before embarking on humanization, and we report the creation of strains and a new gene-editing selection strategy that will be useful for future studies.

摘要

为了研究与额颞叶痴呆( 、 和 )相关的重要基因,我们在三个直系同源基因( 、 和 )中创建了缺失等位基因。同时,我们用预测的直系同源人类 基因替换了 基因,这通常被称为全基因人源化,它允许直接评估保守基因功能,也有机会研究临床疾病相关患者变异的后果。每个基因都使用不同的选择策略进行操作,包括一种使用 突变拯救技术的新策略。临床肌萎缩侧索硬化症/额颞叶痴呆错义变体G272V和P301L成功插入到 中。基于对谷氨酸能噬菌粒神经元的检查,无论是 缺失还是临床变体在年轻成年或老年 中均未引起神经元缺陷。然而,与对照菌株相比,我们注意到P301L 菌株在第9天的存活率下降。基于这些结果,我们评论了人源化策略,包括在进行人源化之前确认 基因预测以及识别每个基因功能缺失缺陷的重要性,并且我们报告了菌株的创建和一种新的基因编辑选择策略,这将对未来的研究有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3762/9530923/8173119a52b6/25789430-2022-micropub.biology.000615.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3762/9530923/8173119a52b6/25789430-2022-micropub.biology.000615.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3762/9530923/8173119a52b6/25789430-2022-micropub.biology.000615.jpg

相似文献

1
The use of CRISPR to generate a whole-gene humanized and the examination of P301L and G272V clinical variants, along with the creation of deletion null alleles of and loci.使用CRISPR生成全基因人源化,并检测P301L和G272V临床变体,以及创建和位点的缺失无效等位基因。
MicroPubl Biol. 2022 Sep 19;2022. doi: 10.17912/micropub.biology.000615. eCollection 2022.
2
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.在一个患有MAPT基因p.P301L突变的家族中出现的家族内可变表型,包括皮质基底节综合征:南美洲首例报告。
Neurobiol Aging. 2017 May;53:195.e11-195.e17. doi: 10.1016/j.neurobiolaging.2017.02.002. Epub 2017 Feb 10.
3
Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.中国额颞叶痴呆患者中MAPT、GRN、C9orf72和CHCHD10基因突变的遗传特征
Curr Alzheimer Res. 2017;14(10):1102-1108. doi: 10.2174/1567205014666170426105713.
4
Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.与微管相关蛋白tau(MAPT)、原纤维蛋白(PGRN)和9号染色体开放阅读框72(C9orf72)基因突变相关的额颞叶痴呆的不同临床和病理表型。
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):497-505. doi: 10.3109/21678421.2015.1074700. Epub 2015 Oct 16.
5
Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.曼彻斯特额颞叶痴呆队列中前颗粒蛋白突变携带者的频率及临床特征:与微管相关蛋白tau(MAPT)突变患者及无已知突变患者的比较
Brain. 2008 Mar;131(Pt 3):721-31. doi: 10.1093/brain/awm331. Epub 2008 Jan 11.
6
Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia.韩国额颞叶痴呆患者中MAPT、GRN和C9orf72基因的临床与遗传学分析。
Neurobiol Aging. 2014 May;35(5):1213.e13-7. doi: 10.1016/j.neurobiolaging.2013.11.033. Epub 2013 Dec 4.
7
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.分析日本额颞叶痴呆、帕金森病伴皮质基底节变性和 C9ORF72 突变患者的 MAPT、PGRN 和 C9orf72 突变。
Parkinsonism Relat Disord. 2013 Jan;19(1):15-20. doi: 10.1016/j.parkreldis.2012.06.019. Epub 2012 Jul 18.
8
Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.MAPT 相关额颞叶痴呆的前驱期和早期病理学特征。
Acta Neuropathol Commun. 2023 Aug 2;11(1):126. doi: 10.1186/s40478-023-01588-9.
9
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.脑蛋白质组中颗粒蛋白前体缺失的网络分析揭示了由 GRN 突变引起的人类额颞叶痴呆的共同发病机制。
Acta Neuropathol Commun. 2020 Oct 7;8(1):163. doi: 10.1186/s40478-020-01037-x.
10
Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia.分析中国额颞叶痴呆患者的微管相关蛋白tau(MAPT)、原纤维蛋白(GRN)和9号染色体开放阅读框72(C9orf72)基因突变。
Neurobiol Aging. 2016 Oct;46:235.e11-5. doi: 10.1016/j.neurobiolaging.2016.05.013. Epub 2016 May 20.

引用本文的文献

1
Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeutics.用于快速诊断遗传变异和发现个体化治疗方法的表型筛选模型。
Mol Aspects Med. 2023 Jun;91:101153. doi: 10.1016/j.mam.2022.101153. Epub 2022 Nov 18.

本文引用的文献

1
Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.在秀丽隐杆线虫中,ALS SOD1 的单拷贝/敲入模型表明,功能丧失和获得对胆碱能和谷氨酸能神经退行性变有不同的贡献。
PLoS Genet. 2018 Oct 8;14(10):e1007682. doi: 10.1371/journal.pgen.1007682. eCollection 2018 Oct.
2
Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.在秀丽隐杆线虫中使用CRISPR-Cas9和线性修复模板进行精确基因组编辑。
Methods. 2017 May 15;121-122:86-93. doi: 10.1016/j.ymeth.2017.03.023. Epub 2017 Apr 7.
3
Rapid and precise engineering of the Caenorhabditis elegans genome with lethal mutation co-conversion and inactivation of NHEJ repair.
利用致死突变共转化和非同源末端连接(NHEJ)修复失活对秀丽隐杆线虫基因组进行快速精确工程改造。
Genetics. 2015 Feb;199(2):363-77. doi: 10.1534/genetics.114.172361. Epub 2014 Dec 9.
4
Simultaneous expression of multiple proteins under a single promoter in Caenorhabditis elegans via a versatile 2A-based toolkit.通过基于 2A 的多功能工具包在秀丽隐杆线虫中单启动子下同时表达多种蛋白质。
Genetics. 2014 Mar;196(3):605-13. doi: 10.1534/genetics.113.160846. Epub 2013 Dec 20.
5
Improved Mos1-mediated transgenesis in C. elegans.秀丽隐杆线虫中经改进的Mos1介导的转基因技术。
Nat Methods. 2012 Jan 30;9(2):117-8. doi: 10.1038/nmeth.1865.
6
Codon adaptation-based control of protein expression in C. elegans.基于密码子适应性的秀丽隐杆线虫中蛋白质表达的控制。
Nat Methods. 2011 Mar;8(3):250-2. doi: 10.1038/nmeth.1565. Epub 2011 Jan 30.
7
Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.携带G272V tau突变的遗传性匹克病表现出主要的三重复tau病理特征。
Brain. 2005 Nov;128(Pt 11):2645-53. doi: 10.1093/brain/awh591. Epub 2005 Jul 13.
8
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier.额颞叶痴呆:P301L tau突变对健康携带者的影响。
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1607-10. doi: 10.1136/jnnp.2003.021295.
9
Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.多聚谷氨酰胺介导的秀丽隐杆线虫感觉神经元功能障碍和凋亡死亡。
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):179-84. doi: 10.1073/pnas.96.1.179.
10
Mutant sensory cilia in the nematode Caenorhabditis elegans.线虫秀丽隐杆线虫中的突变感觉纤毛。
Dev Biol. 1986 Oct;117(2):456-87. doi: 10.1016/0012-1606(86)90314-3.